Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer

NCT01067989 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

22

Enrollment

OTHER

Sponsor class

Stopped No satisfactory acrual

Conditions

Chemotherapy
Breast Cancer, Metastatic

Interventions

DRUG: Cyclophosphamide, Capecitabine, Methotrexate, Celecoxib, Pamidronate (or Zoledronate)

Sponsor

HaEmek Medical Center, Israel